semaglutide and inflammatory bowel disease π§ Disease: Understanding Crohn Ulcerative Colitis β King of the Curve Semaglutide-Associated Ischemic Colitis in a
Description
Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S
Lupus patients considering semaglutide face unique medical complexities
Learn what results to expect on GLP-1/GIP medications after 1, 3, and 6 months
Glucagon-like peptide 1 (GLP-1) agonists represent a novel approach to the management of obesity that has recently attracted considerable attention
Office visits eat up hours
Post-marketing studies are required to confirm long-term clinical benefit
